Advertisement
Screener

MiMedx Group, Inc. (MDXG) Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized

MiMedx Group, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized

MiMedx Group, Inc. (MDXG) reported Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized of 4.00 million shares for the 6-month period ending 2015-06-30, per its 10-Q filed 2015-08-07.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized · last filed 2015-08-07

  • MiMedx Group, Inc. share-based compensation arrangement by share-based payment award, number of additional shares authorized for the quarter ending 2015-06-30 was 0.00 shares.
  • MiMedx Group, Inc. share-based compensation arrangement by share-based payment award, number of additional shares authorized for the quarter ending 2015-03-31 was 4.00M shares, a 0.00% change year-over-year.
  • MiMedx Group, Inc. share-based compensation arrangement by share-based payment award, number of additional shares authorized for the quarter ending 2014-09-30 was 0.00 shares, a 100.00% decline year-over-year.
  • MiMedx Group, Inc. share-based compensation arrangement by share-based payment award, number of additional shares authorized for the quarter ending 2014-06-30 was 0.00 shares, a 100.00% decline year-over-year.
  • MiMedx Group, Inc. share-based compensation arrangement by share-based payment award, number of additional shares authorized for fiscal 2013 was 6.00M shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 12 month
2015-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07
4.00M shares
10-Q · filed 2015-08-07
2015-03-314.00M shares
10-Q · filed 2015-05-01
2014-09-300.00 shares
derived: 10-K 9 month − 10-Q 6 month · filed 2015-03-13
0.00 shares
derived: sum of 2 quarters · filed 2015-03-13
4.00M shares
10-K · filed 2015-03-13
-8.00M shares
derived: sum of 4 quarters · filed 2015-03-13
2014-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11
4.00M shares
10-Q · filed 2014-08-11
-8.00M shares
derived: sum of 3 quarters · filed 2014-08-11
-2.00M shares
derived: sum of 4 quarters · filed 2014-08-11
2014-03-314.00M shares
10-Q · filed 2014-05-12
-8.00M shares
derived: sum of 2 quarters · filed 2014-05-12
-2.00M shares
derived: sum of 3 quarters · filed 2014-05-12
4.00M shares
derived: sum of 4 quarters · filed 2014-05-12
2013-12-31-12.00M shares
derived: 10-K 12 month − 3 quarters · filed 2014-03-04
-6.00M shares
derived: sum of 2 quarters · filed 2014-03-04
0.00 shares
derived: sum of 3 quarters · filed 2014-03-04
6.00M shares
10-K · filed 2014-03-04
2013-09-306.00M shares
10-Q · filed 2013-11-08
12.00M shares
derived: sum of 2 quarters · filed 2013-11-08
18.00M shares
derived: sum of 3 quarters · filed 2013-11-08
2013-06-306.00M shares
10-Q · filed 2013-08-08
12.00M shares
derived: sum of 2 quarters · filed 2013-08-08
2013-03-316.00M shares
10-Q · filed 2013-05-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
ANGIODYNAMICS INC (ANGO)United States$0.632B-13.02
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B
SS Innovations International, Inc. (SSII)$0.589B-64.06
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
CERUS CORP (CERS)United States$0.525B-86.40
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
NeuroPace Inc (NPCE)United States$0.480B-28.52
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
SpyGlass Pharma, Inc. (SGP)United States$0.925B